Alopecia Treatment Market Market 2021 Technology Development, Key Manufacturers Up to 2028

 The global alopecia treatment market size isestimated to reach USD 13,454.16 million by 2027 on account of the increasing number of hair loss cases in people irrespective of gender and age.Alopecia areata is a medical condition that results in hair loss in patches for both males and females. The immune system of the body attacks the hair follicles and ultimately results in loss of hair on the scalp, eyebrows, eyelashes, and face. According to a recent report by Fortune Business Insights titled, “Alopecia Treatment Market Size, Share & Industry Analysis, By Route of Administration (Topical, Injectable, Oral), By Gender Type (Male, Female), By Age Group (Below 18 years, 18 - 34 Years, 35 - 49 Years, Above 50 Years), By End User (Hospitals and Physician Offices, Dermatology Clinics, Others) and Regional Forecast, 2020-2027,” the market value stood at USD 8,894.78 million in 2019 and is anticipated to rise at a CAGR of 5.2% between 2020 to 2027.

for more information: https://www.fortunebusinessinsights.com/alopecia-treatment-market-102822

List of Alopecia Treatment Market Manufacturers include:

  • Follicum AB
  • Concert Pharmaceuticals Inc.
  • Daiichi Sankyo
  • Johnson & Johnson
  • Merck & Co., Inc.,
  • Aclaris Therapeutics, Inc.
  • Fagron
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • GlaxoSmithKline plc.
  • Other Players

Massive Investments on Clinicals will Augment Growth

Various factors are responsible for the alopecia treatment of market growth. These include increasing adoption of a sedentary lifestyle, binge eating habits, cigarette consumption, and others that ultimately weaken the immune system. In addition to this, there is heavy investment in hair transplantation systems, and thiswill also add impetus to the market in the forecast period.

The Middle East and Africa Market to Witness Remarkable Growth with Rising Medical Tourism

Asia Pacific earned a revenue of USD 3,114.14 million in 2019 and emerged dominant. This is attributed to the rising prevalence of alopecia in the region. Various studies state that the increasing population and adoption of a sedentary lifestyle will add impetus to the market in this region. This, coupled with the rising consumption of tobacco may lead to weaker immune systems and increase stress level, thereby leading to hairfall. Additionally, the aggressive regional penetration and the increasing number of hair treatment companies setting up bases will further help this region continue earning the largest alopecia treatment market share in the coming years.

Comments

Post a Comment

Popular posts from this blog

Gene Therapy Market Worldwide Growth, Industry Analysis, Regional Overview, Size and Share Forecast to 2028

  The global gene therapy market is likely to grow at an impressive CAGR over the forecast period, owing to recent technological advancements in gene replacement procedures. According to a report by Fortune Business Insights, titled ‘Gene Therapy: Global Market Analysis, Insights and Forecast, 2018 - 2025’ the market is likely to expand at a high rate due to increasing adoption of gene therapy in several countries across the world. For more information in the analysis of this report, visit:   https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243 Recently, there has been a growing emphasis on development of new gene replacement therapies. Encouraged by advancements in gene therapy and a high demand from end users, many companies are investing more in the research and development (R&D) of these products. According to Fortune Business Insights, in the coming years the market is likely to gain from the rising demand for gene therapy for haemophilia and oth
Read more

Spinal Fusion Devices Market Global Share, Growth, Outlook, Size, Opportunities, Trends, Regional Overview, and 2026

  The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run. Request a Sample Copy of the Market Research Report:   h
Read more

Biomaterials Market | Top 5 company Analysis Report : Before & After effect of covid 19 waves.

  The global “Biomaterials Market” is set to gain impetus from the increasing usage of a wide variety of biomaterials because of their clinical efficiencies. They also provide several benefits in wound healing applications. Fortune Business Insights™ published this information in a recent report, titled, “Biomaterials Market and Industry Analysis, By Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers, and Natural Biomaterials), By Application (Cardiovascular, Dental, Orthopedic, Plastic Surgery, Urology, Gastroenterology, and Others), and Regional Forecast, 2020-2027.” Click here to get the short-term and long-term impact of COVID-19 on this Biomaterials Market. Please visit:  https://www.fortunebusinessinsights.com/biomaterials-market-102770 The report further mentions that the biomaterials market size was USD 110.0 billion in 2019 and is projected to reach USD 245.6 billion by 2027, thereby exhibiting a CAGR of 12.2% during the forecast period from 2020–2027. Segment- Me
Read more